“Our drug industry has been disastrous,” then-President-elect Trump said in his first post-election news conference earlier this month. “They’re getting away with murder.” Okay, murder may be an exaggeration, but pharmaceutical companies are getting away with charging far more for their products in this country than they do in others. But as is often the case, the real problem here is not too little government intervention in the marketplace, but too much.